FULGENT GENETICS INC (FLGT) Stock News

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Fulgent Reports Third Quarter 2024 Financial Results

Uncovering Potential: Fulgent Genetics's Earnings Preview

FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fulgent Genetics (NASDAQ:FLGT) just reported results for the first quarter of 2...

Fulgent to Participate in Upcoming Conferences

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Fulgent Reports Second Quarter 2024 Financial Results

Earnings Preview: Fulgent Genetics

Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer

Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting

Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics

FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024

FLGT stock results show that Fulgent Genetics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Fulgent Reports First Quarter 2024 Financial Results

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

/PRNewswire/ -- CooperSurgical®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company with a...

Mentions: COO

The 3 Best Digital Health Stocks for Personalized Medicine

Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health.

Mentions: ME EXAS

Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference

Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting

Fulgent Genetics Non-GAAP EPS of -$0.39 misses by $0.07, revenue of $84.69M beats by $20.27M (NASDAQ:FLGT)

Fulgent Genetics reports Q3 earnings: non-GAAP EPS misses by $0.07 and revenue beats expectations by $20.27M.

Fulgent Reports Third Quarter 2023 Financial Results

Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting

Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023

Fulgent Reports Second Quarter 2023 Financial Results